J Kolls
Overview
Explore the profile of J Kolls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gopal R, Rangel-Moreno J, Slight S, Lin Y, Nawar H, Fallert Junecko B, et al.
Mucosal Immunol
. 2013 Jan;
6(5):972-84.
PMID: 23299616
The variable efficacy of tuberculosis (TB) vaccines and the emergence of drug-resistant strains of Mycobacterium tuberculosis (Mtb) emphasize the urgency for not only generating new and more effective vaccines against...
2.
Reay J, Kim S, Lockhart E, Kolls J, Robbins P
Cancer Gene Ther
. 2009 Apr;
16(10):776-85.
PMID: 19390568
Interleukin 23 (IL-23) is a member of the IL-12 family of heterodimeric cytokines, composed of p19 and p40 subunits, which exhibits immunostimulatory properties similar to IL-12. IL-23 has been shown...
3.
Lubberts E, Joosten L, van de Loo F, Schwarzenberger P, Kolls J, van den Berg W
Inflamm Res
. 2002 Apr;
51(2):102-4.
PMID: 11930902
No abstract available.
4.
Shellito J, quan Zheng M, Ye P, Ruan S, Shean M, Kolls J
Alcohol Clin Exp Res
. 2001 Jun;
25(6):872-81.
PMID: 11410724
Background: A link between alcohol abuse and bacterial pneumonia has been recognized for centuries, but mechanisms to explain this relationship are unclarified. Interleukin-17 (IL-17) is a lymphocyte-derived cytokine that is...
5.
Ritter T, Brandt C, Prosch S, Vergopoulos A, Vogt K, Kolls J, et al.
Cytokine
. 2000 Aug;
12(8):1163-70.
PMID: 10930292
Viral promoters are commonly used as regulatory elements in gene therapy vectors due to their strong activity in various cell lines in vitro. However, transgene expression under the control of...
6.
Schroder G, Risch K, Nizze H, Kolls J, Reinke P, Brock J, et al.
Transplantation
. 2000 Aug;
70(1):191-8.
PMID: 10919599
Background: E1-deleted adenoviral vectors are frequently used for in vivo gene therapy. However, gene expression after adenovirus-(ad) mediated gene transfer is known to be transient due to the generation of...
7.
Ritter T, Schroder G, Risch K, Vergopoulos A, Shean M, Kolls J, et al.
Gene Ther
. 2000 Aug;
7(14):1238-43.
PMID: 10918493
E1-deleted adenoviral vectors are efficient vectors for somatic gene therapy. Recently, we have shown that intratracheal application of an adenoviral reporter construct leads to significant reporter gene expression in rat...
8.
Shellito J, Tate C, Ruan S, Kolls J
J Infect Dis
. 2000 Jun;
181(6):2011-7.
PMID: 10837183
The recruitment of specific subsets of CD4(+) T lymphocytes to the lungs in response to Pneumocystis carinii was investigated. For mice inoculated with P. carinii, an ELISPOT assay was used...
9.
Ritter T, Risch K, Schroder G, Kolls J, Siegling A, GRASER E, et al.
Transplantation
. 1999 Nov;
68(9):1427-31.
PMID: 10573088
Background: Recently we have demonstrated that the nondepleting anti-CD4 monoclonal antibody (mAb) RIB5/2 induces long-term acceptance of kidney and heart allografts in all rat strain combinations tested. Cytokine gene expression...
10.
Ritter T, Vogt K, Rieck P, Kolls J, Hartmann C, Volk H, et al.
Exp Eye Res
. 1999 Nov;
69(5):563-8.
PMID: 10548477
No abstract available.